Renalytix Plc (RNLXY)
2.71
-0.06
(-1.99%)
USD |
OTCM |
Aug 21, 16:00
Renalytix Debt to Equity Ratio
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2024 | -5.993 |
| September 30, 2024 | -0.7291 |
| June 30, 2024 | -1.087 |
| March 31, 2024 | -0.8477 |
| December 31, 2023 | -1.066 |
| September 30, 2023 | -7.081 |
| June 30, 2023 | 1.740 |
| Date | Value |
|---|---|
| March 31, 2023 | 0.6423 |
| December 31, 2022 | 1.374 |
| September 30, 2022 | 0.591 |
| June 30, 2022 | 0.4032 |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| CompuMed, Inc. | 0.1804 |
| Quest Diagnostics, Inc. | 0.8493 |
| Labcorp Holdings, Inc. | 0.7861 |
| Myriad Genetics, Inc. | 0.6927 |
| OPKO Health, Inc. | 0.3362 |